1. Dual inhibition of EGFR and IL-6-STAT3 signalling by miR-146b: a potential targeted therapy for epithelial ovarian cancer. (1st January 2021) Authors: Yan, Meina; Han, Mutian; Yang, Xinxin; Shen, Rong; Wang, Hui; Zhang, Lubin; Xia, Sheng; Yang, Peifang; Zhai, Guanghua; Shao, Qixiang Journal: Journal of enzyme inhibition and medicinal chemistry Issue: Volume 36:Number 1(2021) Page Start: 1905 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Dynamic changes of serum metabolites associated with infection and severity of patients with acute hepatitis E infection. Issue 6 (7th March 2022) Authors: Wu, Jian; Xu, Yanping; Cui, Yubao; Bortolanza, Mariza; Wang, Minjie; Jiang, Bin; Yan, Meina; Liang, Wei; Yao, Yiwen; Pan, Qiaoling; Yang, Jinfeng; Yu, Jiong; Wang, Dawei; Cao, Hongcui; Li, Lanjuan Journal: Journal of medical virology Issue: Volume 94:Issue 6(2022) Page Start: 2714 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. MiR-146b promotes cell proliferation and increases chemosensitivity, but attenuates cell migration and invasion via FBXL10 in ovarian cancer. Issue 11 (November 2018) Authors: Yan, Meina; Yang, Xinxin; Shen, Rong; Wu, Chengjiang; Wang, Hui; Ye, Qing; Yang, Peifang; Zhang, Lubin; Chen, Miao; Wan, Bing; Zhang, Qinqin; Xia, Sheng; Lu, Xiaodong; Shao, Genbao; Zhou, Xiaoming; Yu, Jun; Shao, Qixiang Journal: Cell death and disease Issue: Volume 9:Issue 11(2018) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗